What is the relationship between constipation and treatment with Glucagon-like peptide-1 (GLP-1) receptor agonists?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Constipation is a common side effect of GLP-1 medications, and managing it requires a multifaceted approach that includes lifestyle modifications and potential over-the-counter medications, as evidenced by the gastrointestinal effects of GLP-1 receptor agonists discussed in 1. To manage constipation while on GLP-1 treatment, it is essential to increase fluid intake to at least 8-10 glasses of water daily and consume more fiber-rich foods like fruits, vegetables, and whole grains, aiming for 25-30 grams of fiber per day. Regular physical activity, even just walking for 30 minutes daily, can help stimulate bowel movements. Some key points to consider when managing constipation with GLP-1 treatment include:

  • Increasing fluid intake to help soften stool and make it easier to pass
  • Consuming more fiber-rich foods to help promote regular bowel movements
  • Engaging in regular physical activity to stimulate bowel movements
  • Considering over-the-counter options like osmotic laxatives, stool softeners, or stimulant laxatives for occasional use These medications work because GLP-1 agonists slow gastric emptying and intestinal transit as part of their mechanism of action, which contributes to weight loss but can lead to constipation, as noted in 1. If symptoms persist despite these measures, or if you experience severe abdominal pain or no bowel movement for more than 3-4 days, it is crucial to consult your healthcare provider as your GLP-1 dosage might need adjustment or additional prescription treatments may be necessary.

From the Research

Constipation with GLP-1 Treatment

  • Constipation is a potential side effect of GLP-1 receptor agonists, which are used to treat type 2 diabetes 2, 3, 4.
  • GLP-1 receptor agonists can slow gastric emptying, which may contribute to constipation 3.
  • The effects of GLP-1 receptor agonists on gastric emptying can decrease over time due to tachyphylaxis 2, 3.
  • Management of constipation in patients with diabetes, including those taking GLP-1 receptor agonists, typically involves dietary changes, exercise, and laxatives 5.
  • Fiber supplementation, particularly with psyllium, can be effective in improving constipation symptoms 6.

Mechanisms of GLP-1 Receptor Agonists

  • GLP-1 receptor agonists stimulate insulin secretion, suppress glucagon secretion, and slow gastric emptying 2, 3, 4.
  • These mechanisms can help improve glycemic control and reduce the risk of cardiovascular events 2, 4.
  • GLP-1 receptor agonists may also have beneficial effects on weight loss and renal function 2, 4.

Treatment of Constipation

  • Dietary changes, including increased fiber intake, can help improve constipation symptoms 5, 6.
  • Laxatives, such as bulking agents, osmotic agents, and stimulants, can be used to treat constipation 5.
  • Fiber supplementation, particularly with psyllium, can be effective in improving constipation symptoms 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Glucagon-like peptide 1 (GLP-1).

Molecular metabolism, 2019

Research

Management of chronic constipation in patients with diabetes mellitus.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2017

Related Questions

What are the effects of Glucagon-like peptide-1 (GLP-1) treatment on chronic constipation?
Do GLP-1 (Glucagon-like peptide-1) receptor agonist drugs cause constipation?
What are the guidelines for protein supplementation in patients taking Glucagon-like peptide-1 (GLP-1) receptor agonists?
Can Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), cause ongoing diarrhea after discontinuation?
Do GLP-1 (Glucagon-like peptide-1) receptor agonists affect stimulant absorption?
What is the diagnosis for a patient with a prolonged Activated Partial Thromboplastin Time (APTT) of 25.0 seconds, low anion gap (Anion) of 4.0, normal osmolality of 276, low C-Reactive Protein (CRP) of 0.1, mild anemia with Hemoglobin of 11.8, microcytic anemia indicated by Mean Corpuscular Volume (MCV) of 77.8, elevated Red Cell Distribution Width (RDW) of 15.6, neutrophilia with a neutrophil count of 76.0, and normal Alanine Transaminase (ALT) of 10?
What is the relationship between constipation and the use of Zepbound (tirzepatide)?
What is the proper referral service for an initial diagnosis of hernia?
What is the proper referral service for an inguinal (in the groin area) hernia?
What is the maximum frequency for using Afrin (oxymetazoline) at 2-3 day intervals to avoid nasal decongestant dependence?
What are the implications of uterine leiomyomatosis (uterine fibroids) with small elements, suggestive findings of endometrial polyp, partially open endometrial cavity with hypoechoic fluid and fine echoes, and a simple cyst on the left ovary?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.